Regencell Bioscience (RGC) had the highest return on April 17, 2024 by a mid-cap US stock, returning 36.1%.

ASSET	DATE	% RETURN
Regencell Bioscience (RGC)	4/17/2024	36.14%
Trump Media & Technology (DJTWW)	4/17/2024	19.27%
Sezzle (SEZL)	4/17/2024	11.72%
PureCycle Technologies (PCTTW)	4/17/2024	10.53%
Trump Media & Technology (DJT)	4/17/2024	8.82%
Inspire Medical Systems (INSP)	4/17/2024	6.81%
Mesoblast (MESO)	4/17/2024	6.37%
Knight Transportation (KNX)	4/17/2024	5.45%
VEON (VEON)	4/17/2024	4.74%
Sunoco (SUN)	4/17/2024	4.63%
Ultragenyx (RARE)	4/17/2024	4.38%
Sunrun (RUN)	4/17/2024	3.78%
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)	4/17/2024	3.72%
Aris Mining (ARMN)	4/17/2024	3.66%
Ormat Technologies (ORA)	4/17/2024	3.41%
Ermenegildo Zegna (ZGN)	4/17/2024	3.34%
Pagaya Technologies (PGY)	4/17/2024	3.3%
American Airlines (AAL)	4/17/2024	3.27%
Terawulf (WULF)	4/17/2024	3.16%
CleanSpark (CLSK)	4/17/2024	3.04%
Paramount Skydance Corporation Class B Common Stock (PSKY)	4/17/2024	2.95%
Immunitybio (IBRX)	4/17/2024	2.95%
BBB Foods (TBBB)	4/17/2024	2.72%
Genius Sports (GENI)	4/17/2024	2.53%
Enel Chile SA ADR (ENIC)	4/17/2024	2.47%

Mid-cap stocks are treated as having a market cap between $2B and $10B.